Copyright ©The Author(s) 2015.
World J Gastroenterol. Mar 14, 2015; 21(10): 3072-3084
Published online Mar 14, 2015. doi: 10.3748/wjg.v21.i10.3072
Figure 6
Figure 6 Responders to therapies based on global symptom score. A: Individual and pooled relative risk in studies comparing probiotics and placebo in irritable bowel syndrome patients; B: Heterogeneity indicators for the studies.